CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Vitamin B12 and Folic Acidother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03283176
NCT03283176N/ACompleted
CompareCT.gov

Changes in Hematologic Profile, Vitamin B12 and Folic Acid Level in Cirrhotic Patients Received Sofosbuvir and Daclatasvir With or Without Ribavirin

Assiut University·observational·Posted Sep 14, 2017·Updated Oct 19, 2020

In Brief

An observational study evaluating Vitamin B12 and Folic Acid for Liver Cirrhoses and 2 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Use of Ribavirin could affect hematologic profile of the patients negatively. With advent of new antiviral therapy, the preexisting hematologic changes may alter or corrected after treatment. However, this point is still not properly studied.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhoses, Chronic Hepatitis c, Directly Acting Antivirals
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 14, 2017
Enrollment StartMar 1, 2018
Primary CompletionMar 1, 2019
Study CompletionJan 14, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.8 years ago

Interventions

Vitamin B12 and Folic Acidother

Vitamin B12 and Folic Acid measurement by ELISA technique